256 related articles for article (PubMed ID: 12919959)
1. Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells.
Chang PL; Cao M; Hicks P
Carcinogenesis; 2003 Nov; 24(11):1749-58. PubMed ID: 12919959
[TBL] [Abstract][Full Text] [Related]
2. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells.
Su L; Mukherjee AB; Mukherjee BB
Oncogene; 1995 Jun; 10(11):2163-9. PubMed ID: 7784060
[TBL] [Abstract][Full Text] [Related]
3. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
Chang PL; Chambers AF
J Cell Biochem; 2000 Apr; 78(1):8-23. PubMed ID: 10797562
[TBL] [Abstract][Full Text] [Related]
4. 1 alpha,25-Dihydroxyvitamin D3 enhances 12-O-tetradecanoylphorbol-13-acetate- induced tumorigenic transformation and osteopontin expression in mouse JB6 epidermal cells.
Chang PL; Prince CW
Cancer Res; 1993 May; 53(10 Suppl):2217-20. PubMed ID: 8485706
[TBL] [Abstract][Full Text] [Related]
5. 1 alpha,25-dihydroxyvitamin D3 stimulates synthesis and secretion of nonphosphorylated osteopontin (secreted phosphoprotein 1) in mouse JB6 epidermal cells.
Chang PL; Prince CW
Cancer Res; 1991 Apr; 51(8):2144-50. PubMed ID: 2009532
[TBL] [Abstract][Full Text] [Related]
6. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
Jansen AP; Colburn NH; Verma AK
Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
[TBL] [Abstract][Full Text] [Related]
7. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
8. Extracellular calcium requirement for promotion of transformation in JB6 cells.
Smith BM; Gindhart TD; Colburn NH
Cancer Res; 1986 Feb; 46(2):701-6. PubMed ID: 3079668
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin mediates tumorigenic transformation of a preneoplastic murine cell line by suppressing anoikis: an Arg-Gly-Asp-dependent-focal adhesion kinase-caspase-8 axis.
Hsieh YH; van der Heyde H; Oh ES; Guan JL; Chang PL
Mol Carcinog; 2015 May; 54(5):379-92. PubMed ID: 24249517
[TBL] [Abstract][Full Text] [Related]
10. Transfer by pro gene transfection of tumor promoter-sensitive phenotype to promotion-insensitive JB6 cells.
Colburn NH; Smith BM; Wendel EJ; Dowjat WK; Shimada T
Cancer Res; 1988 Mar; 48(5):1195-200. PubMed ID: 3342399
[TBL] [Abstract][Full Text] [Related]
11. Four-day duration of tumor promoter exposure required to transform JB6 promotion-sensitive cells to anchorage independence.
Dion LD; Gindhart TD; Colburn NH
Cancer Res; 1988 Dec; 48(24 Pt 1):7126-31. PubMed ID: 3191489
[TBL] [Abstract][Full Text] [Related]
12. Effects of polyphenols derived from fruit of Crataegus pinnatifida on cell transformation, dermal edema and skin tumor formation by phorbol ester application.
Kao ES; Wang CJ; Lin WL; Chu CY; Tseng TH
Food Chem Toxicol; 2007 Oct; 45(10):1795-804. PubMed ID: 17493734
[TBL] [Abstract][Full Text] [Related]
13. Membrane and genetic events in tumor promotion: studies with promoter resistant variants of JB6 cells.
Colburn NH; Lerman MI; Srinivas L; Nakamura Y; Gindhart TD
Princess Takamatsu Symp; 1983; 14():155-66. PubMed ID: 6394588
[TBL] [Abstract][Full Text] [Related]
14. Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells.
Cmarik JL; Li Y; Ogram SA; Min H; Reeves R; Colburn NH
Oncogene; 1998 Jul; 16(26):3387-96. PubMed ID: 9692546
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth factor-beta and retinoic acid.
De Benedetti F; Falk L; Ruscetti FW; Colburn NH; Faltynek CR; Oppenheim JJ
Cancer Res; 1991 Feb; 51(4):1158-64. PubMed ID: 1847657
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways.
Chang PL; Lee TF; Garretson K; Prince CW
Clin Exp Metastasis; 1997 Nov; 15(6):580-92. PubMed ID: 9344042
[TBL] [Abstract][Full Text] [Related]
17. Responses of preneoplastic epidermal cells to tumor promoters and growth factors: use of promoter-resistant variants for mechanism studies.
Colburn NH; Wendel E; Srinivas L
J Cell Biochem; 1982; 18(3):261-70. PubMed ID: 7068782
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by tumor-promoting phorbol esters of procollagen synthesis in promotable JB6 mouse epidermal cells.
Dion LD; Bear J; Bateman J; De Luca LM; Colburn NH
J Natl Cancer Inst; 1982 Nov; 69(5):1147-54. PubMed ID: 6957659
[TBL] [Abstract][Full Text] [Related]
19. Novel protein kinase C isoforms and mitogen-activated kinase kinase mediate phorbol ester-induced osteopontin expression.
Chang PL; Tucker MA; Hicks PH; Prince CW
Int J Biochem Cell Biol; 2002 Sep; 34(9):1142-51. PubMed ID: 12009309
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the antioxidative property of morusin in blocking phorbol ester-induced malignant transformation of JB6 P
Cheng PS; Hu CC; Wang CJ; Lee YJ; Chung WC; Tseng TH
Chem Biol Interact; 2017 Feb; 264():34-42. PubMed ID: 28108223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
